| |
| |
|
| Insider
Information: |
Adelman Burt A |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
12,769 |
|
|
Indirect Shares
|
436,335 |
|
|
| Direct
Value |
$2,872,259 |
|
|
|
Indirect Value
|
$1,801,544 |
|
|
| Total
Shares |
449,104 |
|
|
| Total
Value |
$4,673,803 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
EVP, Portfolio Strategy |
2007-10-15 |
12,769 |
2007-10-15 |
8,009 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
Director |
2021-12-02 |
0 |
2022-05-12 |
428,326 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-07-26 |
4 |
OE |
$49.61 |
$5,705,150 |
D/D |
115,000 |
127,769 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-08-17 |
4 |
AS |
$60.46 |
$1,738,238 |
D/D |
(28,750) |
12,769 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-08-17 |
4 |
OE |
$45.46 |
$1,306,975 |
D/D |
28,750 |
41,519 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-08-27 |
4 |
OE |
$43.50 |
$380,625 |
D/D |
8,750 |
21,519 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-08-27 |
4 |
AS |
$63.50 |
$555,625 |
D/D |
(8,750) |
12,769 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-08-30 |
4 |
AS |
$64.03 |
$2,945,380 |
D/D |
(46,000) |
12,769 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-08-30 |
4 |
OE |
$49.03 |
$2,255,380 |
D/D |
46,000 |
58,769 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-10-15 |
4 |
OE |
$62.28 |
$3,966,315 |
D/D |
60,500 |
73,269 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-10-15 |
4 |
AS |
$82.00 |
$4,961,000 |
D/D |
(60,500) |
12,769 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Director |
– • – |
2021-12-02 |
4 |
B |
$31.34 |
$147,304 |
I/I |
4,700 |
4,700 |
2.1 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Director |
– • – |
2022-03-15 |
4 |
B |
$21.38 |
$85,535 |
I/I |
4,000 |
8,700 |
2.1 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Director |
– • – |
2022-05-12 |
4 |
B |
$12.15 |
$121,526 |
I/I |
10,000 |
18,700 |
2.1 |
- |
|
62 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
